ACUTE LYMPHOBKASTIC LEUKEMIA
Clinical trials for ACUTE LYMPHOBKASTIC LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new ACUTE LYMPHOBKASTIC LEUKEMIA trials appear
Sign up with your email to follow new studies for ACUTE LYMPHOBKASTIC LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New 'Sandwich' therapy aims to stop leukemia relapse after CAR-T
Disease control Not yet recruitingThis study tests a new treatment plan for young adults and adults with B-cell acute lymphoblastic leukemia (B-ALL). The plan combines immunotherapy before a stem cell transplant using the patient's own cells, followed by a 'sandwich' of two types of CAR-T cells (CD22 and CD19). T…
Matched conditions: ACUTE LYMPHOBKASTIC LEUKEMIA
Phase: PHASE2 • Sponsor: The First Affiliated Hospital of Soochow University • Aim: Disease control
Last updated May 26, 2026 05:11 UTC
-
New hope for patients with relapsed leukemia: experimental therapy STR-P004 enters early trial
Disease control Not yet recruitingThis early-phase study tests a new drug called STR-P004 in 11 adults with a type of blood cancer (acute lymphoblastic leukemia) that has come back or not responded to standard treatments. The main goal is to check the drug's safety and find the right dose. Researchers will also l…
Matched conditions: ACUTE LYMPHOBKASTIC LEUKEMIA
Phase: NA • Sponsor: Starna Therapeutics • Aim: Disease control
Last updated May 26, 2026 05:10 UTC
-
Real-World data sought on leukemia drug ponatinib
Disease control Not yet recruitingThis study reviews medical records of about 103 adults with Philadelphia-positive acute lymphoblastic leukemia (Ph+ ALL) who received ponatinib as their first treatment in routine care. Researchers want to see how many patients achieve a deep level of cancer control (complete mol…
Matched conditions: ACUTE LYMPHOBKASTIC LEUKEMIA
Sponsor: Gruppo Italiano Malattie EMatologiche dell'Adulto • Aim: Disease control
Last updated May 26, 2026 05:04 UTC
-
Engineered immune cells take on Hard-to-Treat leukemia and lymphoma
Disease control Not yet recruitingThis study tests a new treatment using a patient's own immune cells, modified to target and kill cancer cells. It is for adults with leukemia or lymphoma that has come back or not responded to standard therapy. The goal is to see if the treatment is safe and can shrink tumors.
Matched conditions: ACUTE LYMPHOBKASTIC LEUKEMIA
Phase: PHASE1, PHASE2 • Sponsor: Minsk Scientific-Practical Center for Surgery, Transplantation and Hematology • Aim: Disease control
Last updated May 26, 2026 04:38 UTC
-
New CAR T-Cell therapy targets Hard-to-Treat blood cancers
Disease control Not yet recruitingThis study tests a new treatment called SHB-02-CD19 for people with certain blood cancers (B-cell malignancies) that have come back or not responded to standard therapy. The treatment uses the patient's own immune cells, modified to recognize and attack cancer cells. The goal is …
Matched conditions: ACUTE LYMPHOBKASTIC LEUKEMIA
Phase: PHASE1, PHASE2 • Sponsor: Sheba Medical Center • Aim: Disease control
Last updated May 14, 2026 12:06 UTC